US Patent Issued to Newcastle University, University of Heidelberg on March 25 for "Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy" (British, German Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,317, issued on March 25, was assigned to Newcastle University (Newcastle, Great Britain) and University of Heidelberg (Heidelberg, Germany).

"Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy" was invented by Hanns Lochmuller (Newcastle Upon Tyne, Great Britain) and Oliver Muller (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides gene therapy vectors, such as adeno-associated virus (AAV) vectors, expressing a functional fragment of the miniaturized human micro-dystrophin gene and method of using these vectors to express the fragment of micro-dystrophin in ske...